Blood culture test sales will expand through 2036, with consumables holding 51.2% of the product segment in 2026, driven by increasing clinical adoption and compliance requirements. The market was valued at USD 5.30 billion in 2025 and is expected to be worth USD 8.97 billion by 2036, creating an incremental opportunity of USD 3.41 billion.